View Published SNOMED CT Subset Metadata

Enhanced Services - Antipsychotic Medication

Subset Name :   
Enhanced Services - Antipsychotic Medication
Subset Original Id :   
Subset Type :   
Realm Concept

Refset FSN :   
Enhanced services general practice extraction - Antipsychotic drugs simple reference set (foundation metadata concept)
Refset Id :   
Refset Type :   

Subset Description :
This subset identifies the drugs as specified in the Enhanced Services - Antipsychotic Medication business rules. These subsets are created using the XML format dm+d data and so within these subsets a small number of concepts are inactive (status 2 or 10) in the International Release. All VMPs and AMPs associated with the following VTMs: Amisulpride Benperidol Chlorpromazine Pericyazine Clozapine Thioridazine Trifluoperazine Sulpiride Risperidone Haloperidol Aripiprazole Promazine Quetiapine Olanzapine Pimozide Levomepromazine Perphenazine Zuclopenthixol Paliperidone Flupentixol dihydrochloride Asenapine Lurasidone The subset only includes VMPs and AMPs that have any of the following drug forms: Capsule Modified-release capsule Modified-release tablet Oral solution Oral suspension Oral lyophilisate Orodispersible tablet Powder Sublingual tablet Suppository Tablet Not applicable Solution for injection Powder for solution for injection Oral drops


Subset Status :   
Draft for Trial Use
Subset Status Date :   
Nov 5, 2018
Owner (Organisation name) :   
NHS Digital

Purpose and Scope

Scope :

Inclusion Criteria :   
Age group - any age; Gender - not specified; Sex - not specified
Subject Category :   
Prescribing; Health Care.Primary care; Chemicals and Drugs


Subset Release Category :   
UK Drug Extension
Language :   
Folder Name :   
File Name :   
Enhanced Services - Antipsychotic Medication

Subset Licence Type :   
IHTSDO SNOMED CT® Licence; UKTC SNOMED CT® Licence; Open Government Licence

Metadata Version :   
Last Updated :   
Nov 27, 2018

Related Links

Subset download with descriptions :

UK Drug Extension releases